Johannes Heuckmann, PhD

Chief Scientific Officer

PearlRiver Bio

Johannes Heuckmann, PhD, serves as Chief Scientific Officer at PearlRiver Bio. Johannes has several years of senior management experience with a successful track record in leading Research & Development and operational activities (IT, Finance, Operations) in the biotech and diagnostics industry.

Johannes developed early small molecule EGFR exon 20 inhibitors and additional scientific discoveries into PearlRiver Bio’s drug development programs and shaped its novel drug discovery platform.

Johannes has also developed several CE-IVD-labeled hybrid capture-based next-generation sequencing (NGS) diagnostic tests (with reagents and software) and successfully built a start-up into a company with more than 50 employees (acquired by Siemens AG in 2016).

Johannes holds a PhD in Cancer Genomics and has broad scientific expertise in targeting resistance mutations and developing diagnostics.

Read more here about PearlRiver Bio

Your browser is out-of-date!

Update your browser to view this website correctly. Outdated Browser